Business context and reporting period
Filing identity: The supplied filing is USEC Inc.’s Form 10-Q for the quarter ended September 30, 2013; it is not filed under the name Centrus Energy Corp. USEC supplied low-enriched uranium (LEU) to nuclear utilities and conducted DOE-funded American Centrifuge research and development. It ceased enrichment at the Paducah plant at the end of May 2013 and was transitioning the site back to DOE. The filing was signed November 5, 2013.
Financial performance and position
| Metric | Q3 2013 | Q3 2012 | Nine months 2013 | Nine months 2012 |
|---|---|---|---|---|
| Revenue | $303.8 million | $563.0 million | $909.0 million | $1,458.8 million |
| Gross profit (loss) | $(30.0) million | $36.6 million | $(63.6) million | $83.5 million |
| Operating income (loss) | $(53.3) million | $13.5 million | $(135.0) million | $(88.1) million |
| Net income (loss) | $(44.3) million | $4.5 million | $(87.2) million | $(116.3) million |
| Operating cash flow | Not separately reported for the quarter | $(104.6) million | $180.5 million |
- Q3 revenue fell 46% year over year, primarily as SWU sales volume declined 47%. Nine-month revenue fell 38%; SWU revenue declined 41%.
- Gross margin was negative 9.9% in Q3 and negative 7.0% for the nine months, versus positive 6.5% and 5.7%, respectively, in 2012. Transition-related non-production expenses were $47.7 million in Q3 and $123.4 million year to date.
- Nine-month net loss improved from 2012, partly reflecting $124.1 million of DOE cost-share income for the centrifuge program and a $35.6 million gain on the sale of NAC International. These items do not indicate improved underlying operating profitability.
- Cash and cash equivalents were $128.4 million at September 30, down from $292.9 million at year-end 2012. Nine-month cash flows were $(104.6) million from operations, $25.7 million from investing, and $(85.6) million from financing; cash declined $164.5 million.
- Working capital was $427.0 million, down from $542.1 million at December 31, 2012. Total assets were $1.704 billion; stockholders’ deficit was $462.1 million. Current assets included $1.177 billion of inventory, while reported net inventory after amounts owed was $700.9 million.
- Debt included $530.0 million of 3.0% convertible senior notes due October 1, 2014. The $110 million credit facility matured September 30, 2013 and was not renewed; available credit was zero. Convertible preferred stock and accrued dividends were reported as a $110.4 million current liability.
Material changes, outlook, and management commentary
- USEC stopped Paducah enrichment in May and was pursuing DOE agreement on site transition and lease termination. It had accrued $32.2 million for Paducah lease-turnover costs; management cautioned that final transition costs could be higher.
- The company’s 2013 outlook was revenue of approximately $1.25 billion from SWU and $70 million from uranium, with SWU delivery volume about 35% below 2012 and average billed SWU price up 2%. Management expected a full-year net loss, approximately $50 million of operating cash flow, and year-end cash above $250 million. The cash forecast was an expectation, not a reported result.
- Management warned that liquidity in 2014 was uncertain, including a projected mid-year cash squeeze because first-quarter Russian supply payments were expected to exceed customer receipts. The company said it needed to restructure the $530 million notes before maturity and could not assure that restructuring or refinancing would succeed.
- The American Centrifuge RD&D program was scheduled to conclude December 31, 2013. Six of nine technical milestones were certified complete as of September 30. DOE had provided $241.3 million of funding, but further funding was not assured. Management said commercialization was not economically viable at prevailing market prices without additional government support and that it might demobilize or terminate the project.
- Commercial deployment was estimated to require at least $4 billion of capital. USEC had applied for a $2 billion DOE loan guarantee and discussed up to $1 billion of Japanese export-credit financing, conditional on a DOE guarantee; neither source was committed. Potential full demobilization costs included about $15 million of employee severance and approximately $40 million of contractual commitments, before other execution costs.
- Material contingencies included a PBGC preliminary estimate of approximately $130 million for potential Portsmouth-related ERISA liability, disputed by USEC; potential Paducah-related exposure could be greater. DOE claims included $80.8 million gross, with a $55.0 million valuation allowance and $25.8 million net long-term receivable. A $42.8 million pension-cost claim was fully reserved.
- NYSE minimum-share-price noncompliance was cured by a 1-for-25 reverse split, but the company remained subject to an accepted market-capitalization compliance plan. Delisting could trigger holders’ right to demand cash repurchase of the notes, which USEC said it could not fund. Other notable items included a 2013 pension freeze for certain employees and $138.3 million of pension remeasurement gain in other comprehensive income.
Important facts for investors to verify
- Confirm the registrant and security identity: this text names USEC Inc., although the request metadata names Centrus Energy Corp.
- Track actual cash generation and year-end liquidity against management’s forecast, and confirm whether customer delivery timing or Russian payment obligations changed.
- Verify any refinancing or balance-sheet restructuring of the October 2014 notes, and the status of credit access and NYSE listing-plan milestones.
- Check DOE appropriations and funding, completion and certification of remaining centrifuge milestones, and any decision to continue, demobilize, or terminate the project.
- Monitor Paducah transition costs, DOE lease arrangements and receivable claims, and PBGC actions or negotiated pension-security requirements.